-
Aldeyra Therapeutics Surges 38%: Here's Why
Monday, February 29, 2016 - 12:11pm | 236Shares of Aldeyra Therapeutics Inc (NASDAQ: ALDX), a nano-cap biotechnology company, surged higher by more than 38 percent Monday morning after the company reported positive results from a Phase IIa clinical trial. Aldeyra Therapeutics reported that the results from a randomized, parallel-group...